Differential expression of prostaglandin h synthase isozymes during multistage carcinogenesis in mouse epidermis
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
An anti–tumor‐promoting effect of indomethacin and related nonsteroidal anti‐inflammatory drugs (NSAIDs) as well as the ability of the tumor promoter 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA) to increase the level of prostaglandins in murine keratinocytes and mouse epidermis in vivo has been repeatedly documented. Here, the expression of prostaglandin H synthase (PGHS) isozymes, which are major targets of NSAIDs, was investigated in different stages of tumor development in mouse skin. Mouse epidermis in vivo constitutively expressed PGHS‐1. PGHS‐1 steady‐state levels remained unchanged upon induction of acute or chronic epidermal hyperplasia by TPA and in papillomas and carcinomas generated by the initiation‐promotion procedure, with 7,12‐dimethylbenz[a]anthracene as initiator and TPA as promoter. Thus, the elevated prostaglandin level in the acute hyperplastic epidermis was very likely due to PGHS‐2 induction. Repeated applications of TPA resulted in stationary hyperplasia and downregulation of PGHS‐2 expression and prostaglandin levels, suggesting that the epidermis had adapted to the TPA stimulus. In papillomas and carcinomas, however, constitutive overexpression of PGHS‐2 was found, with a large amount of prostaglandin E 2 and prostaglandin F 2α. Keratinocyte cell lines corresponding to different stages of tumor development also constitutively over‐expressed PGHS‐2. Considered with inhibitor studies, these data suggest that PGHS‐2 has a critical role in skin carcinogenesis. The anti–tumor‐promoting effect of the PGHS inhibitor indomethacin is specifically reversed by prostaglandin F 2α, indicating that this prostaglandin type has a significant role in tumor development. © 1995 Wiley‐Liss Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., & Vane, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11693 · Cited by 1,659
Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas
Balmain, A., Ramsden, M., Bowden, G. T., & Smith, J. (1984) · Nature · doi:10.1038/307658a0 · Cited by 529
Cited by
Surh, Y.-J., Chun, K.-S., Cha, H.-H., Han, S. S., Keum, Y.-S., Park, K.-K., & Lee, S. S. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00183-x · Cited by 1,620
Herschman, H. R. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00194-8 · Cited by 1,197
Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123
Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., & Dannenberg, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21875 · Cited by 786
Prostaglandin Endoperoxide H Synthases-1 and -2
Smith, W. L., & Dewitt, D. L. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60430-7 · Cited by 711
Buckman, S. (1998) · Carcinogenesis · doi:10.1093/carcin/19.5.723 · Cited by 590
Fischer, S. M., Lo, H.-H., Gordon, G. B., Seibert, K., Kelloff, G., Lubet, R. A., & Conti, C. J. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199908)25:4<231::aid-mc1>3.0.co;2-f · Cited by 408
Inhibition of Cyclooxygenase-2 Gene Expression by p53
Subbaramaiah, K., Altorki, N., Chung, W. J., Mestre, J. R., Sampat, A., & Dannenberg, A. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10911 · Cited by 355
Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition
Pentland, A. P., Schoggins, J. W., Scott, G. A., Khan, K. N. M., & Han, R. (1999) · Carcinogenesis · doi:10.1093/carcin/20.10.1939 · Cited by 328
Zhang, F., Altorki, N. K., Mestre, J. R., Subbaramaiah, K., & Dannenberg, A. J. (1999) · Carcinogenesis · doi:10.1093/carcin/20.3.445 · Cited by 287
Murata, H. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00757-6 · Cited by 279
Langenbach, R., Loftin, C., Lee, C., & Tiano, H. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00158-6 · Cited by 230
LANGENBACH, R., LOFTIN, C. D., LEE, C., & TIANO, H. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08723.x · Cited by 170
Ebselen, a Glutathione Peroxidase Mimetic Seleno-organic Compound, as a Multifunctional Antioxidant
Nakamura, Y., Feng, Q., Kumagai, T., Torikai, K., Ohigashi, H., Osawa, T., Noguchi, N., Niki, E., & Uchida, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109641200 · Cited by 161
Müller-Decker, K. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9306-z · Cited by 73
“However, long-term treatment with the tumor promoter TPA, as required for tumorigenesis in wild-type mice, is not necessary for transgenic mouse lines [182], an effect that was also observed [198] with an independently generated single mouse line with a cytokeratin 14 promoter-driven COX-2 transgene [199].”
InfluentialSelf-citationAhR protein trafficking and function in the skin
Ikuta, T., Namiki, T., Fujii-Kuriyama, Y., & Kawajiri, K. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.003 · Cited by 68
Metadata
- Authors
- Müller‐Decker, K., Scholz, K., Marks, F., & Fürstenberger, G.
- Venue
- Molecular Carcinogenesis
- Publisher
- Wiley
- Published
- 1995-01
- Volume
- 12
- Issue
- 1
- Pages
- 31-41
- ISSN
- 0899-1987 (ISSN-L)
- 1098-2744
- OpenAlex
- W2096952719
- Cited by
- 147
- References
- 2
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.